SLC2A12 and neoplasm: Another study indicated that the diagnostic value of exosomal lncRNA SLC2A12-10:1 in discriminating GC patients from healthy subjects was higher than traditional tumor biomarkers, which highlighted the potential utility of this exosomal lncRNAs as novel tumor markers for GC screening [103].